Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)
Language
Undefined
Purpose: To test methylphenidate (Ritalin®) as a treatment for clinically significant apathy in people with Alzheimer's disease.
Source: Alzheimers Clinical Trials - Category: Geriatrics Authors: chirschman Source Type: clinical trials
More News: Alzheimer's | Clinical Trials | Concerta | Dementia | Geriatrics | Methylphenidate | Ritalin